-
Medicinal Cannabis Science Conference in Toronto
March 1st, 2018 — For those in the cannabis industry interested in the very latest scientific developments they will want to consider attending the upcoming Medicinal Cannabis Conference being held in Toronto, March 23 – 24, 2018, hosted by the International Pharmaceutical Academy at the DoubleTree by Hilton Toronto Downtown. This two-day conference will feature 10 of…
-
9th Circuit Court to decide Future of U.S. CBD Market
February 15th, 2018 – The Hemp Industries Association is taking the U.S. Drug Enforcement Administration to court in a high-stakes case that will decide the future of CBD sales in the U.S. The suit is in response to the DEA’s position that CBD is a marijuana extract and therefore illegal. While the case won’t be decided…
-
Tobacco Industry buys into Hemp & Canadian Cannabis
February 8th, 2018 – Tobacco company Alliance One International Inc. (NYSE:AOI), announced on Thursday news of their 75 percent equity position in Canadian-licensed producer Island Garden Inc. and their 80 percent stake in LP Goldleaf Pharm Inc. With AOI already a major investor in a North Carolina hemp company, this marks the first public entry into…
-
Cannabis Wheaton acquires Uruguayan Hemp CBD producer
January 30th, 2018 – Cannabis Wheaton, a Canadian cannabis streaming company, announced that it had acquired 80% of Uruguay cannabis company Inverell. The Montevideo-based business has a federal license to produce high-CBD, low-THC cannabis strains.Inverell is currently growing the strains on about 40 acres (16 hectares) and has an additional 1,420 acres (574 hectares) available for…
-
PhiVida inks California Hemp products distribution deal
January 4th, 2018 – Phivida Holdings Inc. (“Phivida” or the “Company” traded as (“VIDA:CNX“) or (“PHVAF“) announced today that it has entered into a distribution agreement with Green Reef Distributing Inc. to distribute its products across the State of California. “We are excited to be the first state to launch Phivida’s line of branded CBD-infused functional…
-
CBD Manufacturer Isodiol Buys Pharma Lab Stake
Decenber 10th, 2017 – A CBD manufacturer with offices in Canada and California is moving further into the Canadian cannabis market, acquiring a 25% stake in a company in the final stages of licensing to make hemp and marijuana pharmaceutical products. Isodiol International said it’s acquiring 25% of Canadian National Pharma Group, a pharmaceutical manufacturing…
-
Canada: Government Proposes ‘Micro’ Cultivation Licences
November 21st, 2017 – Canada’s federal government has proposed a licensing program that could allow for ‘micro’ craft cannabis producers to be included in the legal mix. This afternoon, Health Minister Ginette Petitpas Taylor announced the release of a consultation paper detailing the government’s proposed approach to the regulation of cannabis. She also announced the launch of a…
-
Bill C-45: Kills Innovation & Perpetuates Social Harm
November 7th, 2017 – Don Davies is incensed by Trudeau’s plan for legalization, and rightly so. A Member of Parliament from Vancouver, Davies’ recent critique in the house of commons provides a clear-eyed articulation of just how very wrong the Liberal government has got cannabis legalization. Davies says Bill C-45 is not based on evidence…
-
GW Pharma Completes Epidiolex® New Drug Application
October 30th, 2017 – GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome and Dravet Syndrome. GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from…
-
CBD from Industrial Hemp in America
September 7th, 2017 – Production and sale of hemp-derived cannabinoid products continue to expand across the United States. But the legal basis for the markets remains clouded in uncertainty. Cannabinoid products are often derived from the cannabis plant, some of which is still classified as marijuana, which was placed on Schedule I under the federal…